POTASSIUM CHLORIDE SODIUM CHLORIDE & GLUCOSE Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride sodium chloride & glucose

maco pharma (uk) ltd - potassium chloride; sodium chloride; glucose monohydrate - solution for infusion - 0.3/0.18/4 %w/v - electrolytes with carbohydrates

POTASSIUM CHLORIDE, SODIUM CHLORIDE & GLUCOSE Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride, sodium chloride & glucose

maco pharma (uk) ltd - potassium chloride; sodium chloride; glucose monohydrate - solution for infusion - 0.15 0.18 4 %w/v - electrolytes with carbohydrates

POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

potassium chloride in lactated ringers and dextrose- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and

hospira, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0 - potassium chloride 1.79 g in 1000 ml - these solutions are indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. solutions containing lactate are not for use in the treatment of lactic acidosis. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw need

Potassium Chloride 0.3% w/v and Sodium Chloride 0.18% w/v in Glucose 4% w/v Intravenous Infusion BP (Viaflo Container) Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v and sodium chloride 0.18% w/v in glucose 4% w/v intravenous infusion bp (viaflo container)

baxter holding b.v. - potassium chloride; sodium chloride; glucose monohydrate - solution for infusion - 0.3/0.18/4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE- potassium chloride, dextrose monohydrate and sodium chloride injection, solu Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

potassium chloride in dextrose and sodium chloride- potassium chloride, dextrose monohydrate and sodium chloride injection, solu

baxter healthcare corporation - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - potassium chloride 150 mg in 100 ml - potassium chloride in dextrose and sodium chloride injection is indicated as a source of water, electrolytes and calories. potassium chloride in dextrose and sodium chloride injection is contraindicated in patients with: risk summary appropriate administration of potassium chloride in dextrose sodium chloride injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. animal reproduction studies have not been conducted with potassium chloride in dextrose sodium chloride injection. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary sodium and potassium are present in human breast milk. there are no data on the effects

POTASSIUM CHLORIDE & SODIUM CHLORIDE 0.2/0.9 %w/v Solution for Infusion Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride & sodium chloride 0.2/0.9 %w/v solution for infusion

maco pharma (uk) ltd - potassium chloride, sodium chloride - solution for infusion - 0.2/0.9 %w/v - solutions affecting the electrolyte balance

POTASSIUM CHLORIDE & SODIUM CHLORIDE Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride & sodium chloride

maco pharma (uk) ltd - potassium chloride; sodium chloride - solution for infusion - 0.15/0.9 %w/v - electrolytes

POTASSIUM CHLORIDE AND SODIUM CHLORIDE IN GLUCOSE Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride and sodium chloride in glucose

baxter healthcare limited - potassium chloride ; sodium chloride ; glucose monohydrate - solution for infusion - 0.3/0.18/4 %w/v - electrolytes with carbohydrates

POTASSIUM CHLORIDE, SODIUM CHLORIDE AND GLUCOSE 0.3/0.18/4 %w/v Intravenous Inf Solution Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride, sodium chloride and glucose 0.3/0.18/4 %w/v intravenous inf solution

baxter healthcare limited - potassium chloride sodium chloride glucose - intravenous inf solution - 0.3/0.18/4 %w/v

POTASSIUM CHLORIDE, SODIUM CHLORIDE AND GLUCOSE BP 0.15/0.18/ %w/v Intravenous Inf Solution Ирска - Енглески - HPRA (Health Products Regulatory Authority)

potassium chloride, sodium chloride and glucose bp 0.15/0.18/ %w/v intravenous inf solution

baxter healthcare limited - potassium chloride sodium chloride glucose monohydrate - intravenous inf solution - 0.15/0.18/ %w/v